Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20231014059718N1Phase 3Completed
Phase 3, randomised trial in bronchopulmonary diseases comparing Sevoflurane + fentanyl with Propofol + fentanyl (2 arms). Primary endpoints: Severity of cough and Severity of laryngospasm. Started Jan 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20231014059718N1.